Summary
This Form 8-K filing by Kraft Foods Inc. (which would later become Mondelez International) on May 28, 2009, primarily served to disclose information presented during a meeting with Sanford C. Bernstein. The key takeaway for investors is the reaffirmation of Kraft Foods' previously issued full-year guidance for fiscal 2009. Specifically, the company reiterated its expectation of achieving organic net revenue growth of approximately 3 percent and delivering diluted earnings per share (EPS) of $1.88. This confirmation of guidance indicates management's confidence in their strategic initiatives and operational performance amidst the prevailing economic conditions.
Key Highlights
- 1Kraft Foods Inc. reaffirms its fiscal 2009 guidance.
- 2Projected organic net revenue growth for fiscal 2009 remains at approximately 3 percent.
- 3Diluted earnings per share (EPS) guidance for fiscal 2009 is reiterated at $1.88.
- 4Management will present data on narrowing the gap between cumulative pricing and input cost increases since 2003.
- 5The information was shared during a meeting with Sanford C. Bernstein on May 28, 2009.
- 6A slide presentation, including Regulation G reconciliations, was attached as an exhibit.
- 7The company acknowledges risks and uncertainties that could impact forward-looking statements, including input cost volatility and competition.
Frequently Asked Questions
The main purpose of this 8-K filing was to disclose information presented by Kraft Foods Inc. management during a meeting with Sanford C. Bernstein, specifically to reaffirm the company's previously issued financial guidance for fiscal year 2009.
Kraft Foods reaffirmed its expectation for fiscal year 2009 of approximately 3 percent organic net revenue growth and diluted earnings per share (EPS) of $1.88.
This indicates that Kraft Foods believes its pricing strategies and cost management efforts have been effective in mitigating the impact of rising input costs on its profitability since 2003. This is a positive sign for margins and overall financial health.
The company acknowledges that actual results could differ materially from its forward-looking statements due to various risks. These include continued volatility in input costs, pricing actions, increased competition, product mix shifts to lower-margin offerings, international operating risks, challenges in developing markets, and tax law changes.